baber/WOPTO huggingface dataset:
Patent JP-2693189-B2 (JP)
IPC: C07D499/68
Filed: 1988-11-15
Granted: 1997-12-24
Abstract: A new compound called N,N min -carbonyl-bis-(4-ethyl-2,3-dioxo)-piperazine of Formula I <CHEM>   A process for the preparation thereof based on the reaction of 4-ethyl-2,3-dioxo-piperazine or a trimethylsilyl derivative thereof with carbonyl chloride or a derivative thereof. The use of the compound of Formula I as an intermediate in the preparation of compounds of Formula II <CHEM> where R is a radical, substituted in alpha position, of a molecule of an acid selected from the group formed by phenylacetic acid, p-hydroxy phenylacetic acid, a 6-(phenylacetamido)-penicillanic acid and a 7-(phenylacetamido)-cephalosporanic acid.
Patent JP-H0678235-B2 (JP)
IPC: A61K31/00
Filed: 1989-11-18
Abstract: This invention pertains to the novel use of N-acetyl glucosamine as a cytoprotective agent for restoring integrity and normal function of mucous membrane in a human being.
Patent JP-3891617-B2 (JP)
IPC: H01L23/482
Filed: 1996-11-20
Granted: 2007-03-14
Abstract: A method for manufacturing a liquid crystal display is provided. The method includes the steps of forming a gate electrode and a gate line on a substrate, wherein said gate electrode and said gate line comprises at least one refractory metal layer;  forming an insulating film on said gate electrode and said gate line; forming an amorphous silicon film pattern and a doped amorphous silicon film pattern on said insulating film, wherein said doped amorphous silicon film pattern is formed entirely on said amorphous silicon film pattern and a whole bottom surface of said doped amorphous silicon film pattern is directly contacted to said amorphous silicon film pattern; forming a source electrode and a drain electrode composed of a third metal film and then etching away a portion of said doped amorphous silicon film pattern located between said source electrode and said drain electrode; forming a protection film pattern having a first contact hole which exposes a portion of said drain electrode and a second contact hole which exposes a portion of said gate line, wherein said protection film pattern contacts a top surface of said amorphous silicon pattern located between said source electrode and said drain electrode and said insulating film under said second contact hole is etched away to expose a portion of said gate line; and forming a first pixel electrode pattern which is connected to said drain electrode through said first contact hole and a second pixel electrode pattern which is electrically connected to said gate line through said second contact hole. It is thus possible to reduce the number of photolithography processes and to prevent a battery effect and generation of a hillock.  <IMAGE>
Patent JP-3058039-B2 (JP)
IPC: C21C5/56
Filed: 1994-12-22
Granted: 2000-07-04
Abstract: A process for the production of iron from ferrous raw materials in a converter containing an initial iron smelt into which at least fuels, oxygenous gases and ferrous raw materials are introduced during the production phase, the reaction gases being afterburned with oxidizing gases in the gas space of the converter above the smelt and the resulting heat transferred to the iron bath, and a partial amount of iron smelt being tapped after the production phase and a next initial iron smelt remaining in the converter for the next production phase, wherein the weight of the initial iron smelt is between 10 % and 60 % , based on the weigth of the iron smelt present in the converter after the production phase and before the partial amount is tapped, and the ferrous raw materials are fed continuously to the iron smelt through the gas space of the converter during the production phase while at the same time oxygenous gases containing no more than 50 % oxygen are blown continuously onto the surface of the smelt. <IMAGE>
Patent JP-3577604-B2 (JP)
IPC: F16H61/32
Filed: 1993-11-29
Granted: 2004-10-13
Abstract: For use with an automated mechanical transmission system including an electrically actuated shift mechanism (12) having a motor (70, 72), a method of controlling the shift mechanism is provided for shifting the transmission (10) out of gear during a reduced torque shift window by quickly detecting motor motion. The shift mechanism is first energized with a low effective voltage signal (100) to minimize power consumption and avoid overheating the motor, and then with a high effective voltage signal (106) upon detection of motor motion (104), to quickly shift the transmission (10) out of gear. <IMAGE>
Patent JP-H0698346-B2 (JP)
IPC: C02F1/20
Filed: 1990-11-28
Abstract: An apparatus is described for the expulsion of readily volatile pollutants from ground water, and from the ground through which this flows, with the aid of formation of underpressure in a well shaft (10) and also the production of mechanical oscillations in the ground, the energy of which is limited so that they are able to produce molecular liquid movements in the capillaries of the ground layers, without destroying the capillaries. 
<IMAGE>
Patent JP-2936987-B2 (JP)
IPC: H01L25/07
Filed: 1993-12-28
Granted: 1999-08-23
Abstract: PURPOSE:To prevent generation of cracks to improve reliability by using a Cu-base alloy showing the hardness under a high temperature which is only a half of that under the room temperature and also showing a very higher softening temperature for a metallic heat radiating plate of the device where a semiconductor element is mounted on an insulating substrate, metallic heat radiating plate and stress alleviating material on a metallic supporting plate of a power control element. CONSTITUTION:An IGBT module is formed by joining eight (8) Mo blocks 4 consisting of Cu-Cr-Zr heat radiating plate 3 in the thickness of 4mm and a heat stress alleviating material with Sn solder including Au of 20%. Eight semiconductor blocks 4 and electrodes of insulating layer through AlO are joined on the blocks 4 and Cu-Cr-Zr heat radiating plate 3 respectively with Sn-5%Sb solder. Moreover, the AlO ceramics of the insulated substrate 2 and a pure Cu supporting plate 1 are joined with Sn-40%Pb solder and thereafter a lead wire 13 is soldered. After an epoxy case 12 is placed thereon, the inside is filled with silicon gel 9. The metallic supporting plate 1 is made of a Cu group alloy which shows the hardness under a high temperature equal to a half of the hardness under the room temperature and also shows the softening temperature of 350 deg.C or more.
Patent JP-2515434-B2 (JP)
IPC: A61P9/12
Filed: 1990-12-27
Granted: 1996-07-10
Abstract: Compounds of general formula (I) 
<IMAGE>
 in which n represents the number 2, 3, 4 or 5, p represents the number 0 or 1, R1 represents a hydrogen atom or a methyl group, Xm represents one or more atoms or groups chosen from the following: hydrogen, fluorine, chlorine, methoxy, isopropyl or cyclopropyl, in the form of free bases or of addition salts with acids. 
<??>Use in therapy.
Patent JP-H0557014-B2 (JP)
Inventor: SURAITORU UBE BII
IPC: B01D69/02
Filed: 1985-12-23
Abstract: PCT No. PCT/AT85/00060 Sec. 371 Date Aug. 19, 1986 Sec. 102(e) Date Aug. 19, 1986 PCT Filed Dec. 23, 1985 PCT Pub. No. WO86/03685 PCT Pub. Date Jul. 3, 1986.A method for producing a structure comprising at least one membrane with continuous pores having a diameter range of 1 to 8 nm extending along plane, curved, cylindrical or vesicular surfaces consisting essentially of at least one layer of contiguous identical protein containing molecules which molecules are arranged to form a crystal lattice defining continous pores free of said molecules, the membranes being connected to or embedded in a support layer or the membranes being connected together to form a stable unsupported film comprising removing the cell contents from intact cells of microorganisms or breaking the intact cells and separating the membranes or membrane containing cell envelope fragments, suspending the membranes or membrane containing cell envelope fragments in a liquid medium, combining the membranes or membrane containing cell envelope fragments into a layer with a crystal lattice with continuous pores free of the protein containing molecules by depositing the membranes or membrane containing cell envelope fragments onto a support layer or introducing said fragments into a support layer or connecting said fragments together to form a stable unsupported film and a method for altering the effective passage width of the pores of a structure.
Patent JP-2925732-B2 (JP)
IPC: G03D3/06
Filed: 1991-01-09
Granted: 1999-07-28
Abstract: PCT No. PCT/EP91/00123 Sec. 371 Date Jul. 21, 1992 Sec. 102(e) Date Jul. 21, 1992 PCT Filed Jan. 9, 1991 PCT Pub. No. WO91/10940 PCT Pub. Date Jul. 25, 1991.An automatic film processing device replenishment system where an infra red sensor is located to measure silver content of the image on a film or paper carrier, and use the measured silver content for control of replenishment of the process chemicals. In a preferred arrangement a first infra red sensor measures silver content and controls replenishment of developer and bleach and a second infra red sensor measures silver halide content and controls replenishment of fixer.
Patent JP-2930407-B2 (JP)
IPC: G03D3/06
Filed: 1990-02-01
Granted: 1999-08-03
Abstract: In known photographic processing apparatus, quality of the photographs produced can be adversely affected by drift in the paper processor of the apparatus. One cause of drift is incorrect replenishment of the chemicals used in the paper processor. In processing apparatus which utilise only small volumes of chemicals, drift can be caused by replenishment rates not matching the dye formed on the prints being processed, and an operator would need to take steps to adjust the processor. Described herein is an improved method of controlling the replenishment rate of chemicals in photographic processing apparatus. The method comprises deriving a control signal from the image to be exposed on to photographic material and using the derived signal to control the replenishment rate of the chemicals.
Patent JP-3234926-B2 (JP)
IPC: A61J1/10
Filed: 1993-05-12
Granted: 2001-12-04
Abstract: The present invention provides an improved coextruded medical port tubing. The medical port tubing provides characteristics that are desirable in the medical industry and therefore can be used as a medical port tubing in, for example, renal therapy or blood donor tubes. To this end, the present invention provides a coextruded medical grade port tubing comprising: an outer layer comprising a blend of polypropylene copolymer and styrene-ethylene-butylene-styrene copolymer; a tie layer; and a core layer comprising polyvinyl chloride.
Patent JP-3228738-B2 (JP)
IPC: C12N15/09
Filed: 1991-12-20
Granted: 2001-11-12
Abstract: Primers for amplification of specific nucleic acid sequences of the second exon of HLA DQB1 genes and probes for identifying polymorphic sequences contained in the amplified DNA can be used in processes for typing samples from a variety of sources and for detecting allelic variants not distinguishable by serological methods. This HLA DQB1 DNA typing system can be used in a dot blot format that is simple and rapid to perform, produces detectable signals in minutes, and can be used for tissue typing, determining individual identity, and identifying disease susceptible individuals.
Patent JP-H0798745-B2 (JP)
IPC: A01N1/02
Filed: 1989-04-10
Abstract: Improved emulsions of highly fluorinated organic compounds. The emulsions comprise a highly fluorinated organic compound, an oil, that is not substantially surface active and not significantly water soluble, and a surfactant. They are characterized by a well-defined relationship in the relative amounts of the three components.
Patent JP-2555391-B2 (JP)
IPC: C07C233/43
Filed: 1987-09-04
Granted: 1996-11-20
Abstract: New polysubstituted diethylenetriaminepentaacetic acid chelates and protein conjugates of the same are described together with the methods of preparing such compounds. A method of delivering radiolabelled compound of the present invention to a target site while minimizing the distribution of the compound to non-targeted organs or tissues is also disclosed.
Patent JP-2801775-B2 (JP)
IPC: C07C15/02
Filed: 1990-04-09
Granted: 1998-09-21
Abstract: A feedstock containing one or more C9+ aromatic compounds, and optionally toluene, is converted over a catalyst comprising a zeolite possessing a Constraint Index  of 1 to 3 to provide a product which contains substantial amounts of benzene and xylene(s).
Patent JP-4077035-B2 (JP)
IPC: A61M11/00
Filed: 1997-07-22
Granted: 2008-04-16
Abstract: A method of providing a wound dressing is described wherein: liquid is supplied to an outlet in the vicinity of a substrate (7) on which the wound dressing is to be provided, liquid issuing from the outlet is subjected to an electric field to cause the liquid to form at least one jet of electrically charged liquid, the liquid being such that, after formation, the at least one jet forms electrically charged fibre matter which is attracted to and deposits on the substrate (7) to form a mat or web on the substrate (7), and the mat or web is provided with material for promoting or causing tissue repair. A device (9) for providing such a wound dressing is also described. <IMAGE>
Patent JP-2843834-B2 (JP)
IPC: C07D277/42
Filed: 1990-05-15
Granted: 1999-01-06
Abstract: The process of the present invention is the conversion of an aminothiazole (I) to the corresponding thiazole acetic acid (IV) which is a precursor in the preparation of cephalosporin antibiotics.
Patent JP-3457321-B2 (JP)
IPC: G01N33/566
Filed: 1994-09-09
Granted: 2003-10-14
Abstract: The present invention provides for a stable, biologically active CNTF/receptor complex, and hybrids or mutants thereof. The invention is also based in part on the discovery that the CNTF/receptor complex promotes diferentiation through a signal transduction pathway on target cells that do not express the CNTF receptor. The invention further provides for a specific CNTFR mutant that promotes signal transduction without binding CNTF. The invention also provides for a CNTF/receptor blocking mutant, a mutant possessing a high binding affinity to CNTF, but possessing no signal transducing function. The present invention also identifies receptor components shared by the IL-6, CNTF, LIF and OSM signal transduction pathways, and the assay systems based on the use of such components.
Patent JP-4971534-B2 (JP)
IPC: A61K9/08
Filed: 1997-07-31
Granted: 2012-07-11
Abstract: Mannose-6-phosphate is formultated by pH adjustment as a suspension or solution at pH 6 to 8, preferably 6.5 to 7.5 and preferably at a concentration of 65 to 300 mM. Suspensions can be made in viscous hyaluronic acid gels. These compositions are useful in wound healing, particularly to prevent or mitigate scar formation.
Patent JP-3575610-B2 (JP)
IPC: C07D311/16
Filed: 1993-10-06
Granted: 2004-10-13
Abstract: PCT No. PCT/EP93/02742 Sec. 371 Date Apr. 5, 1995 Sec. 102(e) Date Apr. 5, 1995 PCT Filed Oct. 6, 1993 PCT Pub. No. WO94/08985 PCT Pub. Date Apr. 28, 1994Described are 2H-1-benzopyran-2-ones (coumarin derivates) of general formula (I),    <IMAGE>  (I)  wherein R1 is a hydroxyl group, a lower-alkoxy group, a cycloalkoxy group with 4 to 6 C-atoms or the alkyl- or arylsulphonyloxy group R6-SO2O-; R2 and R3, independently of each other, are hydrogen atoms, hydroxyl groups, lower-alkoxy groups or cycloalkoxy groups with 4 to 6 C-atoms; R4 is a hydrogen atom, a lower-alkyl group with 1 to 4 C-atoms or a phenyl group; Y is a nitrogen atom, a CH group or a COH group; R5 is a phenyl, naphtyl, pyridinyl or pyrimidinyl group which may optionally be substituted by one or two C1-C5 alkyl groups, by one or two halogen atoms, by a halogen and C1-C5 alkyl together, by perfluoroalkyl with 1 to 3 C-atoms, by C1-C5 alkoxy, by hydroxy, by methylenedioxy or by nitro; R6 is a lower-alkyl group, a cycloalkyl group with 4 to 6 C-atoms or a phenyl group which may optionally be substituted by one or two C1-C5 alkyl groups, by one or two halogen atoms, or by perfluoroalkyl with 1 to 3 C-atoms; and n=1 to 4; plus their addition compounds with physiologically tolerated acids. Also described are methods of preparing these compounds, novel intermediates in their preparation and methods of preparing such intermediates. The novel coumarin derivatives described possess a neuroprotective and psychopharmacological action. The invention also concerns pharmaceuticals containing these compounds.
Patent JP-2901343-B2 (JP)
IPC: H01L21/00
Filed: 1990-06-21
Granted: 1999-06-07
Abstract: A recirculating chemical bath arrangement includes a quartz process tank, and a sump chamber disposed directly adjacent to the process tank. A trough extends about the top portion of the outer walls of the process tank, the trough being inclined to cause gravital flow toward the sump chamber. The sump chamber includes a fitting in the bottom thereof which directs liquid from the sump into a pump/filter circuit, the output of which is fed into the bottom of the process tank. The liquid is thus caused to overflow the process tank and spill into the trough, and flow into the adjacent sump chamber. A plurality of heater units are secured to the exterior surface of the process tank to heat the liquid therein to the proper process temperature. The sump chamber is unheated, so that the liquid entering the pump/filter is at the coolest temperature of the liquid flow cycle. The process tank and sump chamber may be formed integrally of molded and welded quartz plates, and disposed within an outer case that contains thermal insulation.
Patent JP-3312696-B2 (JP)
IPC: D01F1/07
Filed: 1992-12-17
Granted: 2002-08-12
Abstract: PCT No. PCT/GB92/02349 Sec. 371 Date Jun. 8, 1994 Sec. 102(e) Date Jun. 8, 1994 PCT Filed Dec. 17, 1992 PCT Pub. No. WO93/12173 PCT Pub. Date Jun. 24, 1993.Triazine compounds useful as flame retardants have the formula:   <IMAGE>   where Am represents an amino group, Pp represents a phosphonate group and Z represents an amino group or a phosphonate group, or are polymers comprising repeating units of the formula:   <IMAGE>   where   <IMAGE>   is a diamine residue. The triazine compounds are used as flame retardants in plastics materials, particularly polyurethane foam or artificial fibres, or in intumescent fire protection compositions.
Patent JP-H0734970-B2 (JP)
IPC: B29C33/38
Filed: 1991-10-15
Abstract: PCT No. PCT/GB91/01793 Sec. 371 Date Jun. 15, 1993 Sec. 102(e) Date Jun. 15, 1993 PCT Filed Oct. 15, 1991 PCT Pub. No. WO92/06808 PCT Pub. Date Apr. 30, 1992A water dispersible mould for making a casting, the mould comprising a water-insoluble particulate material-and a binder therefor, the binder including polyphosphate chains and/or borate ions. The invention also provides a process for making a water dispersible mould for making a casting, the process including the steps of: (a) providing a water-insoluble particulate material; (b) combining the particulate material with a binder including polyphosphate chains and/or borate ions, the chains and/or ions being dissolved in water; (c) forming, either during or after step (b), the particulate material and binder mixture into a desired shape; and (d) removing free water from the mixture. The polyphosphate chains may be derived from a water soluble phosphate glass and the borate ions may be derived from a soluble borate glass.
Patent JP-3280026-B2 (JP)
IPC: A23G9/44
Filed: 1993-03-26
Granted: 2002-04-30
Abstract: The method for production of a milk like product is characterized by the fact that transglutaminase is added to a liquid containing milk proteins, that the liquid contains Ca<++>, if required, in an amount sufficient for the reaction catalysed by the transglutaminase, and that the pH of the liquid is adjusted to a value of between 2.8 and 5.2. Hereby a milk like product which is physically more stable than the hitherto known milk like products is obtained. Also in case the milk like product is mixed with fruit juice, the thus generated drink remains stable and homogeneous.
Patent JP-3005817-B2 (JP)
IPC: B60R22/40
Filed: 1995-11-28
Granted: 2000-02-07
Abstract: A safety device comprising: a retractor (22) for protracting and rewinding a safety belt to be worn about an occupant, having a lock wheel (42) and an associated lock pawl (74) movable into engagement therewith upon sensing an emergency condition by a sensing mechanism (50); a pretensioner for rotating the spool in a belt winding direction and a rotary element (80) for converting pretensioner motion to rotary motion and a spring loaded mechanism for providing for locking readiness of the lock pawl and operable after activation of and during rotation of the spool in the belt winding direction. Each of the frame sides includes a positioning hole or opening 70a and 70b through which the tie bar 72 of the present invention extends. If the retractor uses two lock wheels, two such lock pawls would be used.
Patent JP-3518606-B2 (JP)
IPC: A61K38/00
Filed: 1996-02-01
Granted: 2004-04-12
Abstract: PCT No. PCT/EP96/00425 Sec. 371 Date Jul. 31, 1997 Sec. 102(e) Date Jul. 31, 1997 PCT Filed Feb. 1, 1996 PCT Pub. No. WO96/24608 PCT Pub. Date Aug. 15, 1996The present invention refers to basic oxazoline-amide derivatives of GE 2270 and GE 2270-like antibiotics of general formula (I), wherein the group GE represents the antibiotic core molecule. The amide derivatives of antibiotic GE 2270 of formula (I) are antimicrobial agents mainly active against gram positive bacteria.    <IMAGE>  (I)
Patent JP-4326025-B2 (JP)
IPC: H01M50/528
Filed: 1997-05-01
Granted: 2009-09-02
Abstract: An apparatus for loading battery plate groups into a battery box. The apparatus includes a compression frame which includes a number of relative movable walls and stops for gripping and retaining battery groups. The wall carry guide shins for projecting into respective cells in a battery box and guide the groups into the cells as they are pushed by a pusher. The movable nature of the walls allow the groups to be loaded into frame, when it is in released position. The walls can then be drawn together compressing the groups and retaining them in a compressed state as they are loaded.
Patent JP-4237268-B2 (JP)
IPC: C12R1/92
Filed: 1998-05-22
Granted: 2009-03-11
Abstract: Isolated polynucleotide molecules provide recombinant PIV genomes and antigenomes for production of recombinant PIV vaccines. The recombinant genome or antigenome can be expressed with a nucleoprotein (N), phosphoprotein (P), and a large (L) polymerase protein to produce isolated infectious PIV particles. The recombinant PIV genome and antigenome can be modified to produce desired changes, for example to incorporate attenuating mutations from biologically derived PIV mutants or to create chimeric PIV clones, to generate attenuated, immunogenic viruses for vaccine use.
Patent ES-2372951-B2 (ES)
Title: Método de aglomeración de materiales carbonosos.
Inventor: MENDEZ LAZARO ANA MA
IPC: C01B32/384
Filed: 2011-11-18
Granted: 2012-05-21
Abstract: Método de aglomeración de materiales carbonosos
que comprende las etapas de: 
     
         
         - 
         Mezclar el material carbonoso con aceite
girasol como aglomerante, hasta la formación de una pasta
homogénea. 
       
    
     
         
         - 
         Agitar
la mezcla y adicionar pequeñas cantidades de material carbonoso en
polvo manteniendo la agitación de la mezcla. 
       
    
     
         
         - 
         Tamizar el material granular
obtenido. 
       
    
     
         
         - 
         Tratar
el material granular tamizado en aire a temperaturas superiores a
220ºC e inferiores a 270ºC. 
       
    
     
         
         - 
         Enfriar el material granular calentado
y 
       
    
     
         
         - 
         Elevar
la temperatura del material granular a temperaturas superiores a
400ºC en atmósfera seleccionada entre inerte o pobre en
oxígeno.